References
- Aarstad, J., and O. A. Kvitastein. 2023. “Is There a Link between the 2021 COVID-19 Vaccination Uptake in Europe and 2022 Excess All-Cause Mortality?” Asian Pacific Journal of Health Science 10 (1): 25–31.
- Adam, D. 2020. “Modelling the Pandemic. The Simulations Driving the World’s Response to COVID-19.” Nature: 580. https://media.nature.com/original/magazine-assets/d41586-020-01003-6/d41586-020-01003-6.pdf.
- Atanasov, V., N. Barreto, J. Whittle, J. Meurer, B. W. Weston, Q. Luo, L. Franchi, A. Y. Yuan, R. Zhang, and B. Black. 2023. “Understanding COVID-19 Vaccine Effectiveness against Death Using a Novel Measure: COVID Excess Mortality Percentage.” Vaccines 11 (2): 379. https://doi.org/10.3390/vaccines11020379.
- Aven, T. 2016. “Risk Assessment and Risk Management: Review of Recent Advances on Their Foundation.” European Journal of Operational Research 253 (1): 1–13. https://doi.org/10.1016/j.ejor.2015.12.023.
- Aven, T. 2018a. “An Emerging New Risk Analysis Science: Foundations and Implications.” Risk Analysis: An Official Publication of the Society for Risk Analysis 38 (5): 876–888. https://doi.org/10.1111/risa.12899.
- Aven, T. 2018b. “Reflections on the Use of Conceptual Research in Risk Analysis.” Risk Analysis: An Official Publication of the Society for Risk Analysis 38 (11): 2415–2423. https://doi.org/10.1111/risa.13139.
- Aven, T. 2020. “Risk Science contributions - Three Illustrating Examples.” Risk Analysis: An Official Publication of the Society for Risk Analysis 40 (10): 1889–1899. https://doi.org/10.1111/risa.13549.
- Aven, T. 2023. Risk and Risk Science. Oslo: Scandinavian Press,
- Aven, T., and F. Bouder. 2020. “The COVID-19 Pandemic: How Can Risk Science Help?” Journal of Risk Research 23 (7-8): 849–854. https://doi.org/10.1080/13669877.2020.1756383.
- Aven, T., and O. Renn. 2018. “Improving Government Policy on Risk: Eight Key Principles.” Reliability Engineering & System Safety 176: 230–241. https://doi.org/10.1016/j.ress.2018.04.018.
- Aven, T., and S. Thekdi. 2022a. Risk Science: An Introduction. New York: Routledge.
- Aven, T., and S. Thekdi. 2022b. “On How to Characterize and Confront Misinformation in a Risk Context.” J Risk Research 25: 11–12.
- Aven, T., and E. Zio. 2014. “Foundational Issues in Risk Analysis.” Risk Analysis: An Official Publication of the Society for Risk Analysis 34 (7): 1164–1172. https://doi.org/10.1111/risa.12132.
- Axelsson, I. 2021. “Schools Do Not Need to Close to Reduce COVID-19 but Other Measures Are Advisable.” Acta Paediatrica (Oslo, Norway: 1992) 110 (8): 2296–2297. https://doi.org/10.1111/apa.15951.
- Barbari, A. 2021. “COVID-19 Vaccine Concerns: Fact or Fiction?” Experimental and Clinical Transplantation: Official Journal of the Middle East Society for Organ Transplantation Jul19 (7): 627–634. https://doi.org/10.6002/ect.2021.0056. Epub 2021 Mar 31. PMID: 33877041.
- Bardosh, Kevin, Alex de Figueiredo, Rachel Gur-Arie, Euzebiusz Jamrozik, James Doidge, Trudo Lemmens, Salmaan Keshavjee, et al. 2022. “The Unintended Consequences of COVID-19 Vaccine Policy: Why Mandates, Passports and Restrictions May Cause More Harm than Good.” BMJ Global Health 7 (5): E 008684. https://doi.org/10.1136/bmjgh-2022-008684.
- Bauer, Peter, Jonas Brugger, Franz König, and Martin Posch. 2021. “An International Comparison of Age and Sex Dependency of COVID-19 Deaths in 2020: A Descriptive Analysis.” Scientific Reports 11 (1): 19143. https://doi.org/10.1038/s41598-021-97711-8.
- Beladiya, Jayesh, Anup Kumar, Yogesh Vasava, Krupanshu Parmar, Dipanshi Patel, Sandip Patel, Sandip Dholakia, et al. 2024. “Safety and Efficacy of COVID-19 Vaccines: A Systematic Review and Meta-Analysis of Controlled and Randomized Clinical Trials.” Reviews in Medical Virology 34 (1): E 2507. https://doi.org/10.1002/rmv.2507.
- Biggs, A. T., and L. F. Littlejohn. 2021. “Revisiting the Initial COVID-19 Pandemic Projections.” The Lancet. Microbe 2 (3): E91–E92. https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(21)00029-X/fulltext.
- Björkman, A., M. Gisslén, M. Gullberg, and J. Ludvigsson. 2023. “The Swedish COVID-19 Approach: A Scientific Dialogue on Mitigation Policies.” Frontiers in Public Health 2023, 2011: 1206732. https://doi.org/10.3389/fpubh.2023.1206732.
- Calisher, Charles, Dennis Carroll, Rita Colwell, Ronald B. Corley, Peter Daszak, Christian Drosten, Luis Enjuanes, et al. 2020. “Statement in Support of the Scientists, Public Health Professionals, and Medical Professionals of China Combatting COVID-19.” Lancet (London, England) 395 (10226): E 42–e43. https://doi.org/10.1016/S0140-6736(20)30418-9.
- Chen, Q., L. Rodewald, S. Lai, and G. F. Gao. 2021. “Rapid and Sustained Containment of Covid-19 is Achievable and Worthwhile: Implications for Pandemic Response.” BMJ (Clinical Research Ed.) 375: E 066169. https://doi.org/10.1136/BMJ-2021-066169.
- Chiou, H., C. Voegeli, E. Wilhelm, J. Kolis, K. Brookmeyer, and D. Prybylski. 2022. “The Future of Infodemic Surveillance as Public Health Surveillance.” Emerging Infectious Diseases 28 (13): S121–S128. https://doi.org/10.3201/eid2813.220696.
- Chirico, F., J. A. Teixeira da Silva, P. Tsigaris, and K. Sharun. 2022. “Safety & Effectiveness of COVID-19 Vaccines: A Narrative Review.” The Indian Journal of Medical Research Jan155 (1): 91–104. https://doi.org/10.4103/ijmr.IJMR_474_21.
- COA. 2023. Committee Oversight and Accountability. https://oversight.house.gov/release/wenstrup-comer-launch-first-select-subcommittee-investigation-into-covid-origins-and-u-s-taxpayer-dollars-funneled-to-the-wuhan-lab%ef%bf%bc/. Accessed May 8, 2023.
- Collins, A., M.-V. Florin, and O. Renn. 2020. “COVID-19 Risk Governance: Drivers, Responses and Lessons to Be Learned.” Journal of Risk Research 23 (7-8): 1073–1082. https://doi.org/10.1080/13669877.2020.1760332.
- CRS. 2022. Congressional Research Service. Global Pandemics: Gain-of-Function Research of Concern https://crsreports.congress.gov/product/pdf/IF/IF12021. Accessed May 8, 2023.
- Demasi, Maryanne. 2022. “FDA Urged to Publish Follow-up Studies on Covid-19 Vaccine Safety Signals.” BMJ (Clinical Research Ed.) 379: O 2527. https://doi.org/10.1136/bmj.o2527.
- Doshi, P., F. Godlee, and K. Abbasi. 2022. “Covid-19 Vaccines and Treatments: We Must Have Raw Data, Now.” BMJ (Clinical Research Ed.) 376: O 102. https://doi.org/10.1136/bmj.o102.
- EMA. 2021. AstraZeneca’s COVID-19 vaccine: EMA finds possible link to very rare cases of unusual blood clots with low platelets [Text]. European Medicines Agency. https://www.ema.europa.eu/en/news/astrazenecas-covid-19-vaccine-ema-finds-possible-link-very-rare-cases-unusual-blood-clots-low-blood. Accessed May 8, 2023.
- EU. 2023. https://ec.europa.eu/eurostat/statistics-explained/index.php?title=Excess_mortality_-_statistics&oldid=592440. Accessed March 1, 2024.
- EU. 2024. Getting the facts right. European Commission https://commission.europa.eu/strategy-and-policy/coronavirus-response/fighting-disinformation/tackling-coronavirus-disinformation_en. Accessed March 1, 2024.
- Fauci, A. S. 2012. “Research on Highly Pathogenic H5N1 Influenza Virus: The Way Forward.” mBio Nov 1, 3 (5): E 00359-12.https://doi.org/10.1128/mBio.00359-12. PMID: 23047751; PMCID: PMC3484390.
- FDA. 2020a. Food and Drug Administration. Moderna covid-19 vaccine emergency use authorization review memorandum. 2020. www.fda.gov/media/144673/download#page=55. Accessed May 8, 2023
- FDA 2020b. Food and Drug Administration. Pfizer-BioNTech covid-19 vaccine emergency use authorization review memorandum. 2020. www.fda.gov/media/144416/download.
- FHI. 2021. Modelling Scenarios for the SARS-CoV-2 Omicron VOC (B.1.1.529) in Norway during the Winter 2021—2022. Norwegian Institute of Public Health (FHI). https://www.fhi.no/contentassets/e6b5660fc35740c8bb2a32bfe0cc45d1/vedlegg/nasjonale-og-regionale-rapporter/omicron_modelling_report_2021_12_22.pdf. Accessed March 10, 2023.
- Glette-Iversen, I., A. Seif, and T. Aven. 2023. “Characterizations of COVID-19 Risk: Review and Suggestions for Improvement of Current Practices.” Journal of Risk Research 26 (7): 725–747. https://doi.org/10.1080/13669877.2023.2208128.
- Graña, C., L. Ghosn, T. Evrenoglou, A. Jarde, S. Minozzi, H. Bergman, B. S. Buckley, et al. 2022. “Efficacy and Safety of COVID‐19 Vaccines.” The Cochrane Database of Systematic Reviews 12 (12): CD015477. Issue 12. Art. No.: CD015477.https://doi.org/10.1002/14651858.CD015477. Accessed 18 April 2023.
- Gøtzsche, P. C., and M. Demasi. 2023. “Serious Harms of the COVID-19 Vaccines: A Systematic Review.” medRxiv 2022.12.06.22283145. https://doi.org/10.1101/2022.12.06.22283145.
- Hajmohammadi, M., A. S. Malehi, and E. Maraghi. 2023. “Effectiveness of Using Face Masks and Personal Protective Equipment to Reducing the Spread of COVID-19: A Systematic Review and Meta-Analysis of Case–Control Studies.” Advanced Biomedical Research 12: 36. https://doi.org/10.4103/abr.abr_337_21.
- Halma, M. T. J., J. Rose, and T. Lawrie. 2023. “The Novelty of mRNA Viral Vaccines and Potential Harms: A Scoping Review.” J 6 (2): 220–235. https://doi.org/10.3390/j6020017.
- Hansson, S. O. 2013. “Defining Pseudoscience and Science.” In Pigliucci, M. and Boudry, M. Philosophy of Pseudoscience. Chicago: University of Chicago Press, 61–77.
- Hansson, S. O., and T. Aven. 2014. “Is Risk Analysis Scientific?” Risk Analysis: An Official Publication of the Society for Risk Analysis 34 (7): 1173–1183. https://doi.org/10.1111/risa.12230.
- Hansson, S., K. Orru, S. Torpan, A. Bäck, A. Kazemekaityte, S. Frislid Meyer, J. Ludvigsen, L. Savadori, A. Galvagni, and A. Pigrée. 2021. “COVID-19 Information Disorder: Six Types of Harmful Information during the Pandemic in Europe.” Journal of Risk Research 24 (3-4): 380–393. https://doi.org/10.1080/13669877.2020.1871058.
- HFACMS. 2020. The origins of the COVID-19 global pandemic. House Foreign Affairs Committee Minority Staff Interim Report. June 12. https://foreignaffairs.house.gov/wp-content/uploads/2020/08/Interim-Minority-Report-on-the-Origins-of-the-COVID-19-Global-Pandemic-Including-the-Roles-of-the-CCP-and-WHO-8.17.20.pdf. Accessed April 30, 2023.
- Hui, D. S. 2022. “Hybrid Immunity and Strategies for COVID-19 Vaccination.” The Lancet. Infectious Diseases 23 (1): 2–3. https://doi.org/10.1016/S1473-3099(22)00640-5.
- Ioannidis, J. P. A., F. Zonta, and M. Levitt. 2023. “Variability in Excess Deaths across Countries with Different Vulnerability during 2020–2023.” Environmental Sciences 120 (49): e2309557120.
- Jefferson, T., L. Dooley, E. Ferroni, L. A. Al-Ansary, M. L. van Driel, G. A. Bawazeer, M. A. Jones, et al. 2023. “Physical Interventions to Interrupt or Reduce the Spread of Respiratory Viruses.” Cochrane Database of Systematic Reviews, Issue 1. Art. No.: CD006207. https://doi.org/10.1002/14651858.CD006207.pub6.
- Kahneman, D. 2011. Thinking, Fast and Slow. New York: Farrar, Straus and Giroux.
- Khan, F. I., and P. R. Amyotte. 2020. Methods in Chemical Process Safety, vol 4, London: Elsevier.
- Komesaroff, P. A., and D. E. Dwyer. 2023. “The Question of the Origins of COVID-19 and the Ends of Science.” Journal of Bioethical Inquiry 20 (4): 575–583. https://doi.org/10.1007/s11673-023-10303-1.
- Leclercq-Vandelannoitte, A., and J. Aroles. 2020. “Does the End Justify the Means? Information Systems and Control Society in the Age of Pandemics.” European Journal of Information Systems 29 (6): 746–761. https://doi.org/10.1080/0960085X.2020.1820912.
- Leung, K. K., R. Zhang, M. J. Hashim, M. Fang, J. Xu, D. Sun, X. Li, et al. 2022. “Effectiveness of Containment Strategies in Preventing SARS-CoV-2 Transmission.” Journal of Infection and Public Health 15 (6): 609–614. Apr 29, https://doi.org/10.1016/j.jiph.2022.04.012.
- Ludvigsson, J. F. 2023. “How Sweden Approached the COVID-19 Pandemic: Summary and Commentary on the National Commission Inquiry.” Acta Paediatrica (Oslo, Norway: 1992) 112 (1): 19–33. https://doi.org/10.1111/apa.16535.
- Ludvigsson, J. F., L. Engerström, C. Nordenhäll, and E. Larsson. 2021. “Open Schools, Covid-19, and Child and Teacher Morbidity in Sweden.” The New England Journal of Medicine 384 (7): 669–671. https://doi.org/10.1056/NEJMc2026670.
- Lytras, T., M. Athanasiadou, A. Demetriou, D. Stylianou, A. Heraclides, and O. Kalakouta. 2023. “Lack of Association between Vaccination Rates and Excess Mortality in Cyprus during the COVID-19 Pandemic.” Vaccine 41 (18): 2941–2946. Apr 1, S0264-410X(23)00316-X. https://doi.org/10.1016/j.vaccine.2023.03.032. Epub ahead of print.
- Löfstedt, R. 2014. “The Precautionary Principle in the EU: Why a Formal Review is Long Overdue.” Risk Management 16: 137–163.
- NR. 2021. “NIH Admits to Funding Gain-of-Function Research in Wuhan, Says EcoHealth Violated Reporting Requirements. National Review.” Oct 21. Gain-of-Function Research – NIH Admits to Funding Research in Wuhan | National Review.
- NYT. 2020. https://www.nytimes.com/2020/02/13/world/asia/coronavirus-risk-interpreter.html. Accessed April 30, 2023.
- NYT. 2023. Dr. Fauci looks back: Something clearly went wrong. https://www.nytimes.com/interactive/2023/04/24/magazine/dr-fauci-pandemic.html. Accessed April 30, 2023.
- O’Connor, H., W. J. Hopkins, and D. Johnston. 2021. “For the Greater Good? Data and Disasters in a post-COVID World.” Journal of the Royal Society of New Zealand 51 (sup1): S214–S231. https://doi.org/10.1080/03036758.2021.1900297.
- OECD. 2024. OECD.stat https://stats.oecd.org/index.aspx?queryid=104676. Accessed March 1, 2024.
- OWID. 2023. https://ourworldindata.org/excess-mortality-covid.
- Pepples, L. 2020. “What the Days Say about Wearing Face Masks.” Nature 586: 186–189.
- Petersen, M. B., F. Jørgensen, and M. F. Lindholt. 2022. “Did the European Suspension of the AstraZeneca Vaccine Decrease Vaccine Acceptance during the COVID-19 Pandemic?” Vaccine 40 (4): 558–561. https://doi.org/10.1016/j.vaccine.2021.12.026.
- Poortinga, W., and N. F. Pidgeon. 2003. “Exploring the Dimensionality of Trust in Risk Regulation.” Risk Analysis: An Official Publication of the Society for Risk Analysis 23 (5): 961–972. https://doi.org/10.1111/1539-6924.00373.
- Prugger, C., A. Spelsberg, U. Keil, J. Erviti, and P. Doshi. 2021. “Evaluating Covid-19 Vaccine Efficacy and Safety in the Post-Authorisation Phase.” BMJ (Clinical Research Ed.) 375: e067570. https://doi.org/10.1136/bmj-2021-067570.
- Quammen, D. 2023. The ongoing mystery of Covid’s origin. The New York Times,! 8 Aug 2023. https://www.nytimes.com/2023/07/25/magazine/covid-start.html
- Ries, M. 2022. “The COVID-19 Infodemic: Mechanism, Impact, and Counter-Measures—A Review of Reviews.” Sustainability 14 (5): 2605. https://doi.org/10.3390/su14052605.
- Renn, O. 2008. Risk Governance: Coping with Uncertainty in a Complex World. London: Earthscan.
- Selgelid, M. J. 2016. “Gain-of-Function Research: Ethical Analysis.” Science and Engineering Ethics 22 (4): 923–964. https://doi.org/10.1007/s11948-016-9810-1.
- Simon, F. M., and C. Q. Camargo. 2023. “Autopsy of a Metaphor: The Origins, Use and Blind Spots of the ‘Infodemic.” New Media & Society 25 (8): 2219–2240. https://doi.org/10.1177/14614448211031908.
- Slovic, P. 1987. “Perception of Risk.” Science (New York, N.Y.) 236 (4799): 280–285. https://doi.org/10.1126/science.3563507.
- SRA. 2015. Glossary Society for Risk Analysis. https://www.sra.org/resources. Accessed May 1, 2023.
- SRA. 2017a. Core Subjects of Risk Analysis. https://www.sra.org/resources. Accessed, May 1, 2023.
- SRA. 2017b. Risk Analysis: Fundamental Principles. https://www.sra.org/resources. Accessed May 1, 2023.
- Stebbings, Sara, Torill Alise Rotevatn, Vilde Bergstad Larsen, Pål Surén, Petter Elstrøm, Margrethe Greve-Isdahl, Tone Bjordal Johansen, and Elisabeth Astrup. 2022. “Experience with Open Schools and Preschools in Periods of High Community Transmission of COVID-19 in Norway during the Academic Year of 2020/2021.” BMC Public Health 22 (1): 1454. https://doi.org/10.1186/s12889-022-13868-5.
- Sundelson, A. E., A. M. Jamison, N. Huhn, S.-L. Pasquino, and T. K. Sell. 2023. “Fighting the Infodemic: The 4 i Framework for Advancing Communication and Trust.” BMC Public Health 23 (1): 1662. https://doi.org/10.1186/s12889-023-16612-9.
- Sy, W. 2023. “Australian COVID-19 Pandemic: A Bradford Hill Analysis of Iatrogenic Excess Mortality.” Journal of Clinical and Experimental Immunology 8 (2): 542–556.
- Tegnell, A. 2021. “The Swedish Public Health Response to COVID-19.” APMIS: Acta Pathologica, Microbiologica, Et Immunologica Scandinavica 129 (7): 320–323. https://doi.org/10.1111/apm.13112.
- Thacker, B. D. 2021. “Covid-19: Lancet Investigation into Origin of Pandemic Shuts down over Bias Risk.” BMJ (Clinical Research Ed.) 375: N 2414. https://doi.org/10.1136/bmj.n2414.
- The Royal Society. 2023. COVID-19: examining the effectiveness of non-pharmaceutical interventions. file://fil03/emp01/2900055/Documents/paper%202024/the-royal-society-covid-19-examining-the-effectiveness-of-non-pharmaceutical-interventions-report.pdf.
- TIP. 2021. COVID-19: Make it the Last Pandemic. The independent panel. https://theindependentpanel.org/wp-content/uploads/2021/05/COVID-19-Make-it-the-Last-Pandemic_final.pdf. Accessed March 1, 2024.
- Traveller. 2020. Traveller. https://www.smh.com.au/traveller/reviews-and-advice/the-ten-most-bizarre-coronavirus-pandemic-rules-around-the-world-20200818-h1q2wq.html. Accessed March 1, 2024.
- van Helden, Jacques, Colin D. Butler, Guillaume Achaz, Bruno Canard, Didier Casane, Jean-Michel Claverie, Fabien Colombo, et al. 2021. “An Appeal for an Objective, Open, and Transparent Scientific Debate about the Origin of SARS-CoV-2.” Lancet (London, England) 398 (10309): 1402–1404. https://doi.org/10.1016/S0140-6736(21)02019-5.
- Vogt, P. R., L. D. del Valle, and D. R. Fimia. 2023. “COVID-19 and Its Possible Origin.” World Journal of Biological and Pharmaceutical Research 05 (01): 51–56.
- Wang, Y., K. Sun, Y. Pan, L. Yi, D. Huo, Y. Wu, S. Dong, et al. 2022. SARS-CoV-2 containment was achievable during the early stage of the pandemic: A retrospective modelling study of the Xinfadi outbreak in Beijing. medRxiv [Preprint]. 2022 Sep 14:2022.09.12.22279850.
- Walport, M. J. 2023. “Executive Summary to the Royal Society Report "COVID-19: examining the Effectiveness of Non-Pharmaceutical Interventions.” Philos Trans A Math Phys Eng Sci 381 (2257): 20230211.
- WHO. 2020a. Coronavirus disease (COVID-19): Herd immunity, lockdowns and COVID-19. https://www.who.int/news-room/questions-and-answers/item/herd-immunity-lockdowns-and-covid-19. Accessed March 1, 2024.
- WHO. 2020b. Novel Coronavirus(2019-nCoV). Situation report 13, 2 February. Geneva: WHO. Available at: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200202-sitrep-13-ncov-v3.pdf. Assessed March 1, 2024.
- WHO. 2021. Vaccine efficacy, effectiveness and protection. https://www.who.int/news-room/feature-stories/detail/vaccine-efficacy-effectiveness-and-protection. Accessed March 1, 2024.
- WHO. 2024. Infodemics. https://www.who.int/health-topics/infodemic#tab=tab_1
- Wu, Shishi, Rachel Neill, Chuan De Foo, Alvin Qijia Chua, Anne-Sophie Jung, Victoria Haldane, Salma M. Abdalla, et al. 2021. “Aggressive Containment, Suppression, and Mitigation of Covid-19: Lessons Learnt from Eight Countries.” BMJ (Clinical Research Ed.) 375: e067508. https://doi.org/10.1136/bmj-2021-067508.
- Xing, K., X. Y. Tu, M. Liu, Z. W. Liang, J. N. Chen, J. J. Li, L. G. Jiang, F. Q. Xing, and Y. Jiang. 2021. “Efficacy and Safety of COVID-19 Vaccines: A Systematic Review.” Zhongguo Dang Dai Er Ke Za Zhi = Chinese Journal of Contemporary Pediatrics Mar, 23 (3): 221–228.https://doi.org/10.7499/j.issn.1008-8830.2101133. PMID: 33691913; PMCID: PMC7969187.